About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

NCT00127283·167 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novo Nordisk A/S

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Spontaneous intracranial hemorrhage (ICH) within 3 hours after first symptom

You may not be if

Patients with secondary ICH
Pre-existing disability
Haemophilia

The record

StatusCompleted

PhasePhase 3

Taking part829

StartedMay 2005

UpdatedJan 12, 2017

Conditions

Acquired Bleeding Disorder Intracerebral Haemorrhage

Where167

Novo Nordisk Investigational Site
Birmingham, Alabama, United States
Novo Nordisk Investigational Site
Mobile, Alabama, United States
Novo Nordisk Investigational Site
Phoenix, Arizona, United States